28.02.2013 Views

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

488 Daynna Wolff and Stuart Schwartz<br />

37. Weremowicz, S., Sandstrom, D.J., Morton, C.C., Niedzwiecki, C.A., Sandstrom, M.M., and Bieber, F.R. (2001) Fluorescence<br />

in situ hybridization (FISH) for rapid detection <strong>of</strong> aneuploidy: experience in 911 prenatal cases. Prenat. Diagn.<br />

21, 262–269.<br />

38. Tepperberg, J., Pettenati, M.J., Rao, P.N., et al. (2001) Prenatal diagnosis using interphase fluorescence in situ hybridization<br />

(FISH): 2-year multi-center retrospective study and review <strong>of</strong> the literature. Prenat. Diagn. 21, 293–301.<br />

39. Sawa, R., Hayashi, Z., Tanaka, T., et al. (2001) Rapid detection <strong>of</strong> chromosome aneuploidies by prenatal interphase<br />

FISH (fluorescence in situ hybridization) and its clinical utility in Japan. J. Obstet. Gynaecol. Res. 27, 41–47.<br />

40. Witters, I., Devriendt, K., Legius, E., et al. (2002) Rapid prenatal diagnosis <strong>of</strong> trisomy 21 in 5049 consecutive uncultured<br />

amniotic fluid samples by fluorescence in situ hybridisation (FISH). Prenat. Diagn. 22, 29–33.<br />

41. Feldman, B., Ebrahim, S.A., Hazan, S.L., et al. (2000) Routine prenatal diagnosis <strong>of</strong> aneuploidy by FISH studies in<br />

high-risk pregnancies. Am. J. Med. Genet. 90(3), 233–238.<br />

42. Klinger, K., Landes, G., Shook, D., et al. (1992) Rapid detection <strong>of</strong> chromosome aneuploidies in uncultured amniocytes<br />

by using fluorescence in situ hybridization (FISH). Am. J. Hum. Genet. 51, 55–65.<br />

43. Findley, A. (2000) Pre-implantation genetic diagnosis. Br. Med. Bull. 56, 672–690.<br />

44. Munne, S., Marquez, C., Magli, C., Morton, P., and Morrison, L. (1998) Scoring criteria for preimplantation genetic<br />

diagnosis <strong>of</strong> numerical abnormalities for chromosomes X, Y, 16, 18 and 21. Hum. Reprod. 4, 863–870.<br />

45. Harris, N.L., Jaffe, E.S., Diebold, J., et al. (2000) <strong>The</strong> World Health Organization classification <strong>of</strong> neoplasms <strong>of</strong> the<br />

hematopoietic and lymphoid tissues: report <strong>of</strong> the <strong>Clinical</strong> Advisory Committee meeting—Airlie House, Virginia,<br />

November 1997. Hematol. J. 1, 53–66.<br />

46. Palanisamy, N. and Chaganti, R.S.K. (2002). Highly sensitive four-color fluorescent in situ hybridization (F-FISH)<br />

assay for simultaneous detection <strong>of</strong> t(9;22)(q34.1;q11.2) translocation and associated deletions on der(9) and der(22)<br />

chromosomes. Presented at 93rd Annual Meeting <strong>of</strong> American Association for Cancer Research.<br />

47. Dewald, G.W., Wyatt, W.A., and Silver, R.T. (1999) Atypical BCR and ABL D-FISH patterns in chronic myeloid<br />

leukemia and their possible role in therapy. Leukemia Lymphoma 34, 481–491.<br />

48. Sinclair, P.B., Nacheva, E.P., Leversha, M., et al. (2000) Large deletions at the t(9;22) breakpoint are common and may<br />

identify a poor-prognosis subgroup <strong>of</strong> patients with chronic myeloid leukemia. Blood 95, 738–743.<br />

49. Huntly, B.J., Reid, A.G., Bench, A.J., et al. (2001) Deletions <strong>of</strong> the derivative chromosome 9 occur at the time <strong>of</strong> the<br />

Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia.<br />

Blood 98, 1732–1738.<br />

50. Cohen, N., Rozenfeld-Granot, G., Hardan, I., et al. (2001) Subgroup <strong>of</strong> patients with Philadelphia-positive chronic<br />

myelogenous leukemia characterized by a deletion <strong>of</strong> 9q proximal to ABL gene: expression pr<strong>of</strong>iling, resistance to<br />

interferon therapy, and poor prognosis. Cancer Genet. Cytogenet. 128, 114–119.<br />

51. Smoley, S.A., Brockman, S.R., Paternoster, S.F., Meyer, R.G., and Dewald, G.W. (2004) A novel tricolor, dual fusion<br />

fluorescence in situ hybridiation method to detect BCR/ABL fusion in cells with t(9;22)(q34;q11.2) asssociated with<br />

deletion <strong>of</strong> DNA on the derivative 9 chromosome in chronic myelogenous leukemia. Cancer Genet. Cell Genet. 148, 1–6.<br />

52. Andreasson, P., Hoglund, M., Bekassy, A.N., et al. (2000) Cytogenetic and FISH studies <strong>of</strong> a single center consecutive<br />

series <strong>of</strong> 152 childhood acute lymphoblastic leukemias. Eur. J. Haematol. 65, 40–51.<br />

53. Nordgren, A., Heyman, M., Sahlen, S., et al. (2002). Spectral karyotyping and interphase FISH reveal abnormalities not<br />

detected by conventional G-banding. Implications for treatment stratification <strong>of</strong> childhood acute lymphoblastic leukaemia:<br />

detailed analysis <strong>of</strong> 70 cases. Eur. J. Haematol. 68, 31–41.<br />

54. Dohner, H., Stilgenbauer, S., Benner, A., et al. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia.<br />

N. Engl. J. Med. 343, 1910–1916.<br />

55. Dewald, G.W., Brockman, S.R., Paternoster, S.F., et al. (2003) Chromosome anomalies detected by interphase fluorescence<br />

in situ hybridization: correlation with significant biological features <strong>of</strong> B-cell chronic lymphocytic leukemia. Br.<br />

J. Haematol 121, 287–295.<br />

56. Kalachikov, S., Migliazza, A., Cayanis, E., et al. (1997) Cloning and gene mapping <strong>of</strong> the chromosome 13q14 region<br />

deleted in chronic lymphocytic leukemia. Genomics 42, 369–377.<br />

57. Dohner, H., Stilgenbauer, S., James, M.R., et al. (1997) 11q deletions identify a new subset <strong>of</strong> B-cell chronic lymphocytic<br />

leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 89, 2516–2522.<br />

58. Dohner, H., Fischer, K., Bentz, M., et al. (1995) p53 gene deletion predicts for poor survival and non-response to<br />

therapy with purine analogs in chronic B-cell leukemias. Blood 85, 1580–1589.<br />

59. Zandecki, M., Lai, J.L., and Facon, T. (1996) Multiple myeloma: almost all patients are cytogenetically abnormal. Br.<br />

J. Haematol. 94, 217–227.<br />

60. Fonseca, R., Blood, E.M., Rue, M., et al. (2003) <strong>Clinical</strong> and biologic implications <strong>of</strong> recurrent genomic aberrations in<br />

myeloma. Blood 101, 4569–4575.<br />

61. Fonseca, R., Harrington, D., Oken, M.M., et al. (2002) Biological and prognostic significance <strong>of</strong> interphase fluorescence<br />

in situ hybridization detection <strong>of</strong> chromosome 13 abnormalities (∆13) in multiple myeloma: an Eastern Cooperative<br />

Oncology Group study. Cancer Res. 62, 715–720.<br />

62. Drach, J., Ackermann, J., Fritz, E., et al. (1998) Presence <strong>of</strong> a p53 gene deletion in patients with multiple myeloma<br />

predicts for short survival after conventional-dose chemotherapy. Blood 92, 802–809.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!